Bioventus Inc. (BVS) Stock Overview
Explore Bioventus Inc.’s financial performance, market position, analyst ratings, and future outlook.
Bioventus Inc. (BVS)
Key Financials
Key Financials
Market Cap
974.2M
P/E Ratio
17.79
EPS (TTM)
$0.76
ROE
0.28%
BVS Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Bioventus Inc. (NASDAQ: BVS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Bioventus Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BVS on the NASDAQ shows an RSI of 61.68, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $11.35 for the NASDAQ listing.
Key metrics behind Bioventus Inc.'s NASDAQ-traded stock include a P/E ratio of 17.79 and a market capitalization of 974.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BVS on the NASDAQ.